A study reported that quercetin treatment (20 mg/kg) showed a protective effect against HFD-induced NASH by reducing the levels of inflammatory markers TNF-α and myeloperoxidase (MPO) [113]. The gene discussed is TNF; the disease is metabolic dysfunction-associated steatohepatitis.